Maryland bills · 2026 Regular Session
Maryland SB 778
Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Feldman (Democratic)
Summary
No official summary is available for this bill.
Latest action(Apr 28, 2026): Approved by the Governor - Chapter 206
Text versions
- Chapter - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
- Third - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
- First - Clinical Research Pharmacies and Clinical Trials - Permits, Ownership, and Definition of Practice of Medicine
Roll-call votes
State vote data last updated Oct 15, 2026, 8:04 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Mar 31, 2026 House | On Third Reading | pass | Set your home in Maryland to see |
| Mar 5, 2026 Senate | On Third Reading | pass | Set your home in Maryland to see |
Actions
- Apr 28, 2026
Approved by the Governor - Chapter 206 - Apr 13, 2026 · Senate
Returned Passed - Apr 13, 2026 · House
Third Reading Passed - Apr 11, 2026 · House
Favorable Adopted Second Reading Passed - Apr 11, 2026 · House
Favorable Report by Health - Mar 25, 2026 · House
Hearing 4/02 at 1:00 p.m. - Mar 21, 2026 · House
Referred Health - Mar 20, 2026 · Senate
Third Reading Passed - Mar 19, 2026 · Senate
Second Reading Passed with Amendments - Mar 19, 2026 · Senate
Favorable with Amendments { - Mar 19, 2026 · Senate
Favorable with Amendments Report by Finance - Feb 12, 2026 · Senate
Hearing 3/03 at 1:00 p.m. - Feb 6, 2026 · Senate
First Reading Finance